21293249

Source:http://linkedlifedata.com/resource/pubmed/id/21293249

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0017661, umls-concept:C0034656, umls-concept:C0036043, umls-concept:C0087111, umls-concept:C0126174, umls-concept:C0128608, umls-concept:C0205195, umls-concept:C0681867
pubmed:issue	5
pubmed:dateCreated	2011-4-26
pubmed:abstractText	Few have tried to prove the effectiveness of mizoribine combined with losartan for adult IgA nephropathy patients in a randomized controlled trial.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0370506
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin Receptor Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Creatinine, http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Losartan, http://linkedlifedata.com/resource/pubmed/chemical/Ribonucleosides, http://linkedlifedata.com/resource/pubmed/chemical/Uric Acid, http://linkedlifedata.com/resource/pubmed/chemical/bredinin
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	1538-2990
pubmed:author	pubmed-author:ChenPuP, pubmed-author:ChenXiangmeiX, pubmed-author:HuangSongminS, pubmed-author:LieCaihuaC, pubmed-author:LiuShuxinS, pubmed-author:MiaoLiningL, pubmed-author:WangLiL, pubmed-author:WangLiningL, pubmed-author:WuXiongfeiX, pubmed-author:XieYuanshengY, pubmed-author:YingLiL, pubmed-author:ZhangAipingA
pubmed:issnType	Electronic
pubmed:volume	341
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	367-72
pubmed:meshHeading	pubmed-meshheading:21293249-Adult, pubmed-meshheading:21293249-Angiotensin Receptor Antagonists, pubmed-meshheading:21293249-Blood Pressure, pubmed-meshheading:21293249-China, pubmed-meshheading:21293249-Creatinine, pubmed-meshheading:21293249-Drug Synergism, pubmed-meshheading:21293249-Drug Therapy, Combination, pubmed-meshheading:21293249-Female, pubmed-meshheading:21293249-Glomerular Filtration Rate, pubmed-meshheading:21293249-Glomerulonephritis, IGA, pubmed-meshheading:21293249-Humans, pubmed-meshheading:21293249-Immunosuppressive Agents, pubmed-meshheading:21293249-Longitudinal Studies, pubmed-meshheading:21293249-Losartan, pubmed-meshheading:21293249-Male, pubmed-meshheading:21293249-Prospective Studies, pubmed-meshheading:21293249-Proteinuria, pubmed-meshheading:21293249-Ribonucleosides, pubmed-meshheading:21293249-Treatment Outcome, pubmed-meshheading:21293249-Uric Acid
pubmed:year	2011
pubmed:articleTitle	Efficacy and safety of mizoribine combined with losartan in the treatment of IgA nephropathy: a multicenter, randomized, controlled study.
pubmed:affiliation	Department of Nephrology, Chinese PLA General Hospital, Beijing; China.
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study